During the past decade, Nemocnice Znojmo conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nemocnice Znojmo" #1 sponsor was "Bayer" with 2 trials, followed by "Celgene" with 1 trials sponsored, "Cogentus Pharmaceuticals" with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Galapagos NV" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nemocnice Znojmo" #1 collaborator was "Parexel" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Nemocnice Znojmo" are "Acute Coronary Syndrome" (1 trials), "Bowel Cleanliness" (1 trials), "Chemotherapy-Induced Nausea and Vomiting" (1 trials), "Chronic Kidney Failure" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Nemocnice Znojmo" in a lesser frequency.

Most popular intervention types in "Nemocnice Znojmo" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Finerenone (BAY94-8862)" (2 trials), "Aprepitant" (1 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnice Znojmo" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Nemocnice Znojmo". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Nemocnice Znojmo, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnice Znojmo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".